HIV combination therapy: Partial immune restitution unmasking latent cryptococcal infection

AIDS

Volumn 12, Issue 12, 1998, Pages 1491-1494

  Woods II, Marion L ^a   MacGinley, Robert ^a   Eisen, Damon P ^a   Allworth, Anthony M ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Antiviral therapy; Cellular immunity; Opportunistic infections

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; LAMIVUDINE; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; MENINGITIS, FUNGAL;

EID: 0032552169     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199812000-00011     Document Type: Article

References (18)

1. Eron J, Benoit SL, Jemsek J, et al.: Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party. N Engl J Med 1995, 333:1662-1669.
2. Collier A, Coombs R, Shoenfeld D, et al.: Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Engl J Med 1996, 334:1011-1017.
3. Rozenbaum R, Goncalves AJR: Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994, 18:369-380.
4. Buchanan KL, Murphy JW: Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect Immun 1994, 62:2930-2939.
5. Retini C, Vecchiarelli A, Monari C, et al.: Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect Immun 1996, 64:2897-2903.
6. Modlin RL, Pirmez C, Hofman FM, et al.: Lymphocytes bearing antigen-specific gamma/delta T-cell receptors in human infectious diseases lesions. Nature 1989, 339:544-548.
7. Sampaio EP, Kaplan G, Miranda A, et al.: The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J Infect Dis 1993, 168:408-414.
8. Sampaio EP, Sarno EN, Galilly R, et al.: Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991, 173:699-703.
9. American Thoracic Society and the Centers for Diseases Control and Prevention: Treatment of tuberculosis and tuberculosis infection adults and children. Am J Respir Crit Care 1994, 149:1359-1374.
10. Hejazi N, Hassler W: Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy. Review of the literature and own experience. Acta Neurochir 1997, 139:194-202.
11. Kumarvelu S, Prasad K, Khosla A, et al.: Randomized controlled trial of dexamethasone in tuberculous meningitis. Tubercle Lung Dis 1994, 75:203-207.
12. Huang ZB, Eden E: Effect of corticosteroids on IL1 beta and TNF alpha release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia. Chest 1993, 104:751-755.
13. Jacobson MA, Zegans M, Pavan PR, et al.: Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997, 349:1443-1445.
14. Race EM, Adelson-Mitty J, Kriegel G R, et al.: Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998, 351:252-255.
15. Yoo J, Chen K, Kraus T, et al.: Altered cytokine production and accessory cell function after HIV-1 infection. J Immunol 1996, 157:1313-1320.
16. Newman GW, Guarniaccia JR, Vance EA III, et al.: Interleukin- 12 enhances antigen-specific proliferation of peripheral blood mononuclear cells from HIV-positive and negative donors in response to Mycobacterium avium. AIDS 1994, 8:1413-1419.
17. Zhang T, Kawakami K, Qureshi MH, et al.: Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun 1997, 65:3594-3599.
18. Bisset LR, Rothen M, Joller-Jemelka HI, et al.: Changes in circulating macrophage inflammatory proteins 1α and 1β, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. AIDS 1997, 11:485-491.